Lepodisiran, an extended-duration short interfering RNA targeting lipoprotein(a): a randomized dose-ascending clinical trial
Sikiric P, Skrtic A, Gojkovic S, Krezic I, Zizek H, Lovric E, Sikiric S, Knezevic M, Strbe S, Milavic M, Kokot A, Blagaic AB, Seiwerth S
Tendon and Ligament Healing: Animal models involving transected Achilles tendons or damaged medial collateral ligaments have shown that BPC-157 can significantly accelerate the healing process
Neither ipamorelin nor CJC-1295 is FDA-approved as a finished drug product
This will facilitate the clinical application of SCF-based compound preparations, improve drug quality evaluation, and lay the foundation for developing functional foods and health supplements